◀ Back to CD8A
CD8A — GP2
Text-mined interactions from Literome
Gorse et al., AIDS Res Hum Retroviruses 2001
(HIV Infections) :
There was a possible association between HIV-1 envelope
glycoprotein stimulated interleukin 2 secretion and
CD8 ( + ) CTLs against HIV-1 envelope glycoprotein, and an inverse relation between lymphocyte proliferation and CTLs against HIV-1 Gag antigens
Campbell et al., Clin Immunol 2002
(Carcinoma, Hepatocellular...) :
A 180-kDa
glycoprotein ( gp180 ) has been identified and shown to be
important in
CD8 ( + ) T cell activation by intestinal epithelial cells
Gorse et al., Clinical and vaccine immunology : CVI 2006
(HIV Infections) :
Mean frequencies of HIV-1 envelope
glycoprotein stimulated , activated intra-cellular IFN-gamma producing CD4 ( + ) and
CD8 ( + ) lymphocytes and of interleukin-2 producing CD4 ( + ) lymphocytes did not increase after vaccination, but cytokine producing cells were detectable in some patients
Kim et al., Clin Immunol Immunopathol 1991
(Autoimmune Diseases) :
It has been shown previously that there is a strong correlation between the in vitro release of soluble CD8
glycoprotein ( sCD8 ) and
CD8+ T lymphocyte
activation
Mallick et al., PloS one 2013
(Sarcoma, Experimental) :
Neem leaf
glycoprotein activates
CD8 ( + ) T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcoma
Toy et al., J Clin Invest 1997
(Colitis, Ulcerative...) :
A 180-kD
glycoprotein ( gp180 ) recognized by mAbs B9 and L12 has been identified and shown to be
important in
CD8+ T cell activation by IEC